Experiment 930290

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

EUGLOBAL I-B

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismEmpty organism
CitationTAKASAKI,M: KONOSHIMA,T: FUJITANI,K: YOSHIDA,S: NISHIMURA,H: TOKUDA,H: NISHINO,H: IWASHIMA,A: KOZUKA,M:. (1990). INHIBITORS OF SKIN-TUMOR PROMOTION. VIII. INHIBITORY EFFECTS OF EUGLOBALS AND THEIR RELATED COMPOUNDS ON EPSTEIN-BARR VIRUS ACTIVATION.. 38(10)
Amount utilized
Compound isolated
DiseaseVS.12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION. 16.5% INHIBITION.
Dose amount3.2 MICROMOLS
Number3
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED